Reply to ‘Significance of NT-proBNP as a prognostic marker in patients with hypertension’

Courand, Pierre‐Yves; Grandjean, Adrien; Harbaoui, Brahim; Lantelme, Pierre

doi:10.1097/hjh.0000000000002402

Cited by 1 publication

(2 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The NT-proBNP level has a predictive value regarding the risk of cardiovascular complications in patients with AH [11,12]. To determine the prognostic value of NT-proBNP in comorbid patients under our supervision, the optimal value of the distribution point, an excess of which is associated with the risk of developing cardiovascular complications/events in patients with AH, was found by ROC analysis to be 411.7 pg/mL.…”

Section: Ah Ah + Obesity Ah + т2dm Ah + Obesity + т2dmmentioning

confidence: 99%

See 1 more Smart Citation

Natriuretic Peptide: Diagnostic, Prognostic, and Clinical Relevance in Patients With Type 2 Diabetes Mellitus, Arterial Hypertension and Obesity

Dunaieva

2024

PEP

View full text Add to dashboard Cite

Natriuretic peptides are one of the main biomarkers of chronic heart failure (CHF). The level of NT-proBNP makes it possible to evaluate the negative prognosis in patients with CHF, as well as to monitor the sensitivity of patients with left ventricular dysfunction to the appointment of treatment. The purpose of the study: to study the NT-proBNP biomarker in comorbid patients with hypertension, obesity, type 2 diabetes and determine the relationship with a number of hormonal and biochemical indicators. Materials and methods: all patients were divided into 4 groups depending on the presence of comorbid pathology in them: patients with hypertension – 1 group – 22 people; patients with hypertension combined with obesity – group 2 – 30 people; Hypertension in combination with type 2 diabetes – group 3 – 31 people; patients with hypertension, type 2 diabetes and obesity – group 4 – 28 people. Determination of the content of N-terminal brain natriuretic peptide (NT-proBNP) in the blood serum of patients was carried out by the immunoenzymatic method on the analyzer "Labline-90" (Austria) using a commercial test system manufactured by the company "Elabscience" (ELISA, China) according to the instructions, which was part of the set. Conclusions. It was established that in patients with hypertension, hypertension in combination with obesity, hypertension in combination with type 2 diabetes, as well as hypertension in combination with type 2 diabetes and obesity, there is a significant increase in NT-proBNP compared to the indicator of the control group (p<0.05). It has been proven that NT-proBNP has a direct correlation with creatinine (p=0.045), urea (p=0.038), triglyceride level (p=0.027) and cholesterol (p=0.031); direct correlation with the level of HbA1c (r=0.202; p=0.0038). The level of NT-proBNP has a significant predictive value for the risk of developing cardiovascular complications in patients with hypertension.

show abstract

Section: Ah Ah + Obesity Ah + т2dm Ah + Obesity + т2dmmentioning

confidence: 99%

“…It has been found that BNP is an independent predictor of cardiovascular disease. An increase in the level of this peptide may indicate the presence of chronic heart failure, myocardial ischemia, pulmonary hypertension, and arterial hypertension [10,11].…”

mentioning

confidence: 99%

Natriuretic Peptide: Diagnostic, Prognostic, and Clinical Relevance in Patients With Type 2 Diabetes Mellitus, Arterial Hypertension and Obesity

Dunaieva

2024

PEP

View full text Add to dashboard Cite

show abstract

Reply to ‘Significance of NT-proBNP as a prognostic marker in patients with hypertension’

Cited by 1 publication

References 6 publications

Natriuretic Peptide: Diagnostic, Prognostic, and Clinical Relevance in Patients With Type 2 Diabetes Mellitus, Arterial Hypertension and Obesity

Natriuretic Peptide: Diagnostic, Prognostic, and Clinical Relevance in Patients With Type 2 Diabetes Mellitus, Arterial Hypertension and Obesity

Contact Info

Product

Resources

About